First_author;Last_author;Journal;Publication_year;Gene_number;List;Technology;Cancer;Comments;Title;Doi;author_journal_year
R Cabrita;G Jönsson;Nature;2020;9;CD79B, CD1D, CCR6, LAT, SKAP1, CETP, EIF1AY, RBP5, PTGDS;SAM analysis and scRNA-seq;Melanoma;identify genes overexpressed in CD8+CD20+ versus CD8+ groups and subtracted the genes overexpressed in CD8+ versus double-negative groups. Two groups, which were independent of tumour core and patient, were clearly discerned on the basis of Ki67 expression.;Tertiary lymphoid structures improve immunotherapy and survival in melanoma;https://doi.org/10.1038/s41586-019-1914-8;RCabrita_Nature_2020
L de Chaisemartin;M-C Dieu-Nosjean;Cancer Research;2011;13;CCL19, CCL21, CXCL13, CCL17, CCL22, IL16, ICAM2, ICAM3, VCAM1, MADCAM1, ITGAL, ITGA4, ITGAD;Laser microdissection and qPCR;Lung;T cell presence in TLS;Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer;10.1158/0008-5472.CAN-11-0952;LdeChaisemartin_CancerResearch_2011
D Coppola;J J Mulé;The American Journal of Pathology;2011;12;CCL2, CCL3, CCL4, CCL5, CCL8, CCL18, CCL19, CCL21, CXCL9, CXCL10, CXCL11, CXCL13;mRNA Microarray;Colorectal;12-chemokine gene signature;;;Dcoppola_CanRes_2011
G Bindea;J Galon;Immunity;2013;1;CXCL13;DNA microarray;Colorectal;only 1 gene;Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer;http://dx.doi.org/10.1016/j.immuni.2013.10.003;GBindea_Immunity_2013
M Meylan;W H Fridman;Immunity;2022;29;IGHA1, IGHG1, IGHG2, IGHG3, IGHG4, IGHGP, IGHM, IGKC, IGLC1, IGLC2, IGLC3, JCHAIN, CD79A, FCRL5, MZB1, SSR4, XBP1, TRBC2, IL7R, CXCL12, LUM, C1QA, C7, CD52, APOE, PTLP, PTGDS, PIM2, DERL3;Visium Spatial transcriptomics;Renal;TLS imprint;Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer;https://doi.org/10.1016/j.immuni.2022.02.001;MMeylan_Immunity_2022
I P. MacFawn;T C Bruno;Cancer Cell;2024;20;ARHGDIB, BIRC3, CD52, CD79A, CORO1A, CXCL9, CYTIP, LCP1, LIMD2, LSP1, LTB, PLEK, POU2AF1, PTPRC, PTPRCAP, RCSD1, SELL, TAGAP, WIPF1, TRBC1;DSP;Ovarian;By setting a threshold of 2-fold enrichment in the “TLS” enriched DEGs, we produced a 20-gene “TLS-DSP” signature;;https://doi.org/10.1016/j.ccell.2024.09.007;IP.MacFawn_CancerCell_2024
X Wang;C Sotirou;Nature Communications;2024;30;CD79A, CD79B, TNFRSF13C, BLK, CD22, CD37, MS4A1, NIBAN3, CD19, IKZF3, LINC00926, CXCR5, LTB, SELL, CCL19, POU2AF1, CXCL13, FCRLA, VPREB3, FCMR, AL928768.3, RASGRP2, TCF7, RIPOR2, RAC2, IL16, CCR7, CD52, TCL1A, ATP2A3;ST Arrays;Breast;comparing gene expression data from TLS versus lymphocyte compartment as well as TLS versus other non-immune-related compartments;;;XWang_NatureCommunications_2024
R Wu;L Chen;Science Advances;2021;50;FDCSP, CR2, CXCL13, LTF, CD52, MS4A1, CCL19, LINC00926, LTB, CORO1A, CD79B, TXNIP, CD19, LIMD2, CD37, ARHGAP45, BLK, TMC8, CCL21, PTPN6, ATP2A3, IGHM, SPIB, TMSB4X, CXCR4, NCF1, CD79A, ARHGAP9, DEF6, EVL, TBC1D10C, RASAL3, INPP5D, RNASET2, RASGRP2, TNFRSF13C, RAC2, CD22, ARHGEF1, AC103591.3, TRAF3IP3, HLA-DQB1, CD53, ARHGAP4, TRBC2, POU2AF1, TRAF5, OGA, FCRL3, HLA-DQA1;Visium Spatial transcriptomics;Liver;;;;RWu_ScienceAdvances_2021
Y Zhang;D Chen;Science Advances;2024;83;RPS15A, LTB, RPS11, CCL5, LSP1, CD3D, AKNA, CCL19, TRBC1, RPL18A, CD44, HLA-DPB1, CYBA, 1-Sep, RPS27, TRAC, HLA-DRB1, TBC1D10C, ZAP70, ZFP36L2, HLA-DQA1, CD52, RPL21, JAK3, CD37, SRGN, RASAL3, CD79A, RPS6, CXCR4, LIMD2, ATP2A3, CD79B, RACK1, TSC22D3, RPL13, ARHGAP45, LAPTM5, ACAP1, ARHGAP4, GMFG, LDHB, TRBC2, RPS3, IGFBP7, CD74, HLA-DRA, CIRBP, COL6A2, RPS3A, CCL21, EVL, CD2, RAC2, NOP53, LAT, CORO1A, HLA-E, IL7R, TXNIP, HCST, FXYD5, RASGRP2, RPL34, ARHGDIB, ARHGEF1, HLA-DQB1, ITGB2, DEF6, EMILIN1, RPS9, VWF, LUM, IGHM, KLF2, GSTP1, HSPG2, HLA-DMA, AEBP1, CCDC85B, VSIR, MFAP4, INMT;83 gene signature;Pancreatic;;10.1126/sciadv.adp4942;;YZhang_ScienceAdvances_2024